News

Vect-Horus

VECT-HORUS announces a new equity issue of 1.5 M€ to finance the preclinical development of its first vectorized product

VECT-HORUS announced today having raised € 1.5 million, from its historical shareholders, mostly professionals in the finance industry. In total, VECT-HORUS raised in 9 years more than € 11 million, of which € 5 million in grants and research tax credit, a record in France for equity financing of a biotechnology company.

The public-private research collaboration developed with the CNRS, Aix -Marseille University (AMU), the CEA and INSERM has allowed VECT-HORUS to develop a portfolio of four international patent families, some already issued in Europe and the United States.